Company
Onconetix, Inc. (ONCO)
Standardized SEC financial data for Onconetix, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001782107 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
-67.7%
Return on equity
-89.0%
Free cash flow
-$9.7M
Current ratio
0.66×
EPS (diluted)
$-16.56
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $58K | $2.5M | $815K |
| Cost of revenue | — | — |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.3M | $1.9M | $25.8M | $4.6M | $647K | $5.2M |
| Inventory |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$2.0M | -$8.7M | -$13.6M | -$10.5M | -$9.7M |
| Capital expenditures | $2K | $80K |
Get ONCO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ONCO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ONCO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"